Pharmacy Times
JANUARY 26, 2024
By offering personalized guidance, promoting awareness, and fostering open communication, pharmacists can empower their patients to navigate the new year with a focus on both wellness and safety.
STAT
JANUARY 26, 2024
There are more openly LGBTQ+ people in the U.S. than ever, but little is known about the unique health challenges they may face. That’s why some researchers are urging health systems to build the acronym SOGIE — for patients’ sexual orientation and gender identity and expression — into their data collection. In a paper published Wednesday in JAMA Cardiology , a group of cardiologists write that there is an urgent need to begin collecting SOGIE data more systematically
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
JANUARY 26, 2024
Jennifer Marsh, PharmD, BCCCP, discusses the current standard of care for hepatic encephalopathy, highlighting challenges in treatment, prescription drug coverage, transition of care, and outpatient treatment access.
Fierce Healthcare
JANUARY 26, 2024
As artificial intelligence advances in different areas of healthcare, there are concerns that technology and AI-based chatbots will replace the human connections between patients and practitioners. | A new study finds promising potential for AI and large language models to enhance mental health therapy at scale by being able to analyze millions of text-based counseling messages to shine a light on what works.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Fierce Pharma
JANUARY 26, 2024
Merck’s unique approval for Keytruda as a postsurgical treatment for resectable kidney cancer has gained new backing in the form of data showing the PD-1 inhibitor can extend patients’ lives. | Merck’s unique approval for Keytruda as a postsurgerical treatment for resectable kidney cancer has gained new backing in the form of data showing the PD-1 inhibitor can extend patients’ lives.
STAT
JANUARY 26, 2024
When I enter, “what is pediatrics?” into an image search engine, I get back dozens of stock photos with smiling physicians listening to beaming children’s hearts or looking in their ears. I love those images. They reflect the routine joy and trust that encompass many days in the life of a pediatrician. Increasingly, though, the answer to that question doesn’t quite match the happy imagery.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
JANUARY 26, 2024
WASHINGTON — Merck CEO Robert Davis and Johnson & Johnson CEO Joaquin Duato have agreed to voluntarily testify before the Senate health committee, avoiding a threatened subpoena, the committee announced Friday. The decision by the executives came after a public pressure campaign by Sanders to get the two executives and Bristol Myers Squibb CEO Chris Boerner to testify about why prices for their drugs are higher in the United States than in other countries.
Fierce Healthcare
JANUARY 26, 2024
Cognoa, maker of the first FDA-approved autism diagnostic tool, announced Highmark has signed on as its first commercial payer partner. | The tool, Canvas Dx, leverages AI to empower doctors to quickly and accurately diagnose developmental risk without bias, the company claims. It is the first FDA-approved autism diagnostic tool.
Pharmacy Times
JANUARY 26, 2024
Compared to TACE alone, durvalumab plus TACE and bevacizumab reduced the risk of disease progression or death by 23%; however, further research is needed to assess OS.
Fierce Healthcare
JANUARY 26, 2024
In the age of artificial intelligence, things are moving at warp speed, noted UNC Health CIO Brent Lamm. | “We have been very aggressive over the past 12 to 18 months at UNC Health to seek out any and every opportunity to try to remove or reduce the administrative burden for our provider teams," CIO Brent Lamm said.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Fierce Pharma
JANUARY 26, 2024
With the unusual threat of a Senate subpoena hanging over their heads, the CEOs of Johnson & Johnson and Merck & Co. | With the unusual threat of a Senate subpoena hanging over their heads, the CEOs of Johnson & Johnson and Merck & Co. have agreed to join their counterpart at Bristol Myers Squibb in testifying before the Senate Committee on Health, Education, Labor and Pensions (HELP).
STAT
JANUARY 26, 2024
Covid vaccines saved nearly 20 million lives worldwide, by one estimate, and generated billions of dollars for several drugmakers. But investment in experimental vaccines for dozens of other diseases remains modest and should be much higher, according to a new biotechnology industry report. Even with the historic effort to develop coronavirus vaccines, including shots created by Cambridge, Mass.
Fierce Pharma
JANUARY 26, 2024
The combination of Merck's Keytruda and Pfizer and Astellas' Padcev recently made waves in bladder cancer—and the broader oncology world—by delivering a massive life-extension benefit against | The combination of Merck's Keytruda and Pfizer and Astellas' Padcev recently made waves in bladder cancer—and the broader oncology world—by delivering a massive life-extension benefit.
Drug Topics
JANUARY 26, 2024
Compared to only 10% of primary and subspecialty visits, 34.5% of mental health visits took place via video in August 2023.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Fierce Healthcare
JANUARY 26, 2024
State Medicaid agencies are required to cover Hepatitis C medications for people who have the disease or a substance use disorder, states were "encouraged" earlier this week. | State Medicaid agencies were reminded of their responsibility to offer Hepatitis C medications, or direct-acting antivirals (DAAs), to individuals with substance use disorder.
Pharmacy Times
JANUARY 26, 2024
Pharmacists can also ensure proper education and selection of therapy before and after discharge.
Pharmaceutical Commerce
JANUARY 26, 2024
Concerns regarding hypoglycemia potentially linked to a counterfeit version of Ozempic come at a time in which reports have grown regarding the improper use of GLP-1 receptor agonists for the purpose of cosmetic weight loss.
Drug Topics
JANUARY 26, 2024
Smartphone apps were effective at promoting weight loss and reducing BMI, but had no impact on HbA1c levels or waist circumference.
Fierce Pharma
JANUARY 26, 2024
At Sanofi and Regeneron, it’s all about the kids—at least with respect to their recent advancements of anti-inflammatory powerhouse Dupixent. | The FDA has signed off on Sanofi and Regeneron's Dupixent to treat children between the ages of 1 and 11 who weigh at least 33 pounds with eosinophilic esophagitis. Dupixent becomes the first treatment in the U.S. for children in this age group with the disorder.
Fierce Healthcare
JANUARY 26, 2024
Blue Shield of California is offering to foot the bill for Medicaid enrollees who want to earn a General Education Diploma and become high school graduates. | The program, being rolled out in Los Angeles and San Diego counties, addresses a trend of fewer people graduating from high school.
Fierce Pharma
JANUARY 26, 2024
In late 2022, GSK, Sanofi and Takeda signed on with a partnership of local agencies to advance biologic manufacturing in Singapore. | In late 2022, GSK, Sanofi and Takeda signed on with a partnership of local agencies to advance biologic manufacturing in Singapore. Now, a little more than a year later, AbbVie is getting in on the action by starting a major production expansion in the Garden City.
STAT
JANUARY 26, 2024
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hello, everyone. Damian here with a look at a biotech rarity, a milestone on Wall Street, and pharma’s latest run-in with Washington.
Fierce Pharma
JANUARY 26, 2024
Shortly after Europe’s Committee for Medicinal Products for Human Use (CHMP) recommended refusal of a marketing authorization | Shortly after Europe’s Committee for Medicinal Products for Human Use (CHMP) recommended refusal of marketing authorization for Apellis’ geographic atrophy (GA) drug Syfovre (pegcetacoplan injection), the company said it will appeal the guidance.
The Checkup by Singlecare
JANUARY 26, 2024
Ozempic (semaglutide) is one of the most popular prescription drugs for treating Type 2 diabetes on the market. Approved by the Food and Drug Administration (FDA) in 2017 for blood sugar management, Ozempic has recently gained attention for its weight loss effects. Healthcare professionals prescribe Ozempic off-label for weight management for patients with obesity.
Drug Store News
JANUARY 26, 2024
David Snow, founder, chairman and CEO of Cedar Gate Technologies, discusses how value-based care has changed over the years and its current challenges.
STAT
JANUARY 26, 2024
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is still shaping up. We do, however, plan to catch up on our reading, promenade with the official mascots, and hold another listening party with Mrs. Pharmalot. For now, the rotation will likely include this , this , this and this.
Drug Store News
JANUARY 26, 2024
The Hispanic chain will now be part of the Fresco Retail Group, an investment group from Coral Gables, Fla. specializing in the food and grocery industries.
STAT
JANUARY 26, 2024
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.
Pharmacy Times
JANUARY 26, 2024
These patients may have a similar genetic susceptibility for type 2 diabetes.
pharmaphorum
JANUARY 26, 2024
Eli Lilly is weeks away from launching Mounjaro in the UK, after getting approval from the MHRA for a multi-dose injector version for diabetes and obesity
Pharmacy Times
JANUARY 26, 2024
In hospital pharmacies, roughly 2% of pharmacy spend can be overcharge.
pharmaphorum
JANUARY 26, 2024
AbbVie has broken ground on a new $223 million expansion of its biologics manufacturing facility in Singapore, creating around 100 new jobs
Pharmaceutical Commerce
JANUARY 26, 2024
A non-randomized control trial investigates whether older adults with multiple chronic conditions can benefit by receiving more specialized services.
pharmaphorum
JANUARY 26, 2024
Report on UK biotech sector by Tony Blair and William Hague calls for an NHS trust to be set up to oversee and sell patient data
Expert insights. Personalized for you.
149 
Let's personalize your content